NYRA Medical
Health Care · Cardiovascular Devices
$12Mlatest round · Venture round · Nov 2022 · 4 yr ago
2backers · Broadview Ventures, Epidarex Capital
17team · US Form 5500 (plan participants) · Dec 2025 · +42% in a year
2018founded
Overview
Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.
Funding and backers
Total raised
$12M
1 round on record
Latest round
$12M
Venture round · Nov 2022 · 4 yr ago
Team
17
US Form 5500 (plan participants) · Dec 2025 · +42% in a year
Backers
2
Broadview Ventures, Epidarex Capital
The money's age
Long since its last round
48 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team of 17 was 12 · US Form 5500 (plan participants)
Nov 10, 2022
Raised a round Venture round $12M · SEC Form D
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2022 | $12M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Nyra Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Sai Muralidhar PadalaExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Capstan Medical
backs Xeltis
Similar startupsby what they do, their industry and backers
Innovating a Better Way. CroíValve’s mission is to help patients suffering from tricuspid regurgitation with a new, minimally invasive…
Direct Repair On A Beating Heart The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option…
— Reshaping treatment for Functional Mitral Regurgitation (FMR) Transcatheter Leaflet Restoration (TLR) system is engineered to work in…
Capstan Medical develops robotically delivered heart valve implants for minimally invasive structural heart repair. Its system combines a…
Xeltis is an international medical technology company developing vascular and valve implants that transform into living blood vessels…
Innovating Valve Repair. Versa Vascular is leading development of a novel tricuspid valve repair solution in Santa Cruz, California.
Visa sponsorship
1
H-1B filings in 12 months
$123k
Median offered salary
0
Open roles in United States
Who they sponsor
Bioengineers and biomedical engineers
1
In the register as Nyra Medical, Inc., Atlanta, GA
Other sponsors in the same field
Eko 
Synapse Biomedical
Medtronic 
Boston Scientific
Alert me
US Department of Labor · latest filing Apr 13, 2026 · Visa details by country
Financials
Total raised
$12M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $12M | Details |
People
Sai Muralidhar Padala
Executive Officer, Director
Amrinder Singh
Director
Eric Sarin
Director
Gowri Raman
Director
Lisa Heine
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Epidarex CapitalVia a fund
Broadview VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Nyra Medical Announces First Patient Enrollment in ENHANCE Early Feasibility Study, Advancing Next Generation Mitral Valve Repair Platform
Read more
Report
Nyra Medical Receives Prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at EuroPCR 2026
Read more
Report
Nyra Medical to Highlight First-in-Human Clinical Insights Through Three Presentations at EuroPCR
Nyra Medical, a leading innovator in structural heart therapies, today announced its participation in the upcoming EuroPCR meeting, where the company will be featured in three key presentations underscoring continued its growing clinical validation, physi
Read more
Report
Nyra Medical Announces Initiation of First-in-Human Clinical Trial for Novel Mitral Valve Repair Device
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Decatur
United States
HQ
Atlanta
United States
Regional office
Learn More About CARLEN and Our Trials
1120 Curran St NW, Suite C, Atlanta, GA 30318